Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new paper published today by the Oxford Martin School calls for ‘open science’ approaches to drug discovery and offers ways forward that would transform how the medical challenges of this century could be addressed more efficiently.

Drug discovery must change to urgently address global health needs.jpg

A New Pharmaceutical Commons: Transforming Drug Discovery ’, written by Professor Chas BountraDr Wen Hwa Lee, and Dr Javier Lezaun, highlights the limits of traditional R&D models focussed on secrecy and the protection of Intellectual Property (IP) rights, and offers a set of recommendations for strengthening pre-competitive and open source practices that can accelerate the race for cures to the world’s most harmful diseases.

Read more (Oxford Martin School website)